Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 28, 2017; 23(28): 5115-5126
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5115
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5115
Figure 2 Myo-inositol reduces inflammation in IL-10-/- Px mice.
A: Representative MPO staining of the proximal-distal junction in IL-10-/- control, IL-10-/- Px and IL-10-/- Px/myo-inositol colon at day 28; B: Histological grading of colitis shows that myo-inositol reduces the severity of inflammation, the extent (thickness) of inflammation, and the combined colitis score. Untreated IL-10-/- mice did not exhibit inflammation at day 28. Values represent the mean ± SE, n = 4 mice in each group.
- Citation: Bradford EM, Thompson CA, Goretsky T, Yang GY, Rodriguez LM, Li L, Barrett TA. Myo-inositol reduces β-catenin activation in colitis. World J Gastroenterol 2017; 23(28): 5115-5126
- URL: https://www.wjgnet.com/1007-9327/full/v23/i28/5115.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i28.5115